GYNECONCEPTS

GyneConcepts is seeking the right partner to purchase this technology and market it to women worldwide. Are you that partner? Will you be the one?... Our singular goal is to make medical testing and treatment more convenient, affordable, accessible and psychologically comfortable for women worldwide. In view of these goals, GyneConcepts, Inc. has patented the world's first Cervical Cell Collection Device, the Privacy Pap Smear (PPS), that the patient can easily administer herself, on her own schedule, in the privacy of her own home or doctor's office. In addition to global patent coverage, the PPS is now certified with the CE Mark in the European Union as a Class 1, Non-Sterile device. Unlike current self-sampling methods on the market that collect vaginal cells only for HPV analysis, the PPS collects cervical cells that can be analyzed for cervical cytology, chlamydia, and gonorrhea as well as HPV. The PPS enhances the single most powerful weapon to defeat cervical cancer: early..

Also known as: GyneConcepts, Inc.

Primary location: Atlanta United States